MapLight Therapeutics Director George Pavlov Receives Equity Awards

This Form 4 filing reports equity awards granted to George Pavlov, a director of MapLight Therapeutics, Inc. On June 23, 2026, Pavlov received 3,932 restricted stock units (RSUs) representing a contingent right to receive shares of voting common stock, and 14,902 stock options with an exercise price of $28.64 per share. Both awards were granted under the company's 2025 Equity Incentive Plan as part of non-employee director compensation. The awards will vest on the earlier of June 23, 2027, or the date of the company's next annual stockholder meeting, subject to Pavlov's continued service as a director. Following these grants, Pavlov holds 28,932 shares of common stock and 14,902 stock options. The filing demonstrates the company's ongoing director compensation practices and equity incentive program.